Corton Capital Inc. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Corton Capital Inc. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$40,031
-69.7%
12,628
-52.5%
0.02%
-67.7%
Q2 2023$132,127
-19.3%
26,585
-19.8%
0.06%
-45.6%
Q1 2023$163,761
-23.7%
33,150
-2.8%
0.11%
-35.6%
Q4 2022$214,539
-12.4%
34,108
+50.1%
0.18%
-40.8%
Q3 2022$245,000
-37.3%
22,716
-33.8%
0.30%
-19.0%
Q2 2022$391,000
+92.6%
34,336
+54.0%
0.37%
+319.3%
Q1 2022$203,000
-48.3%
22,296
-15.4%
0.09%
-49.4%
Q4 2021$393,00026,3410.17%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders